XML 37 R24.htm IDEA: XBRL DOCUMENT v3.25.2

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share

As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $0.001 per share), these shares are deemed to be issued for purposes of basic earnings per share.

The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:

		Year Ended December 31,
		2024				2023
		(As Restated)
(In thousands, except share and per share data)
Weighted-average common shares outstanding, basic and diluted			48,543,787				24,619,197
Weighted-average shares outstanding of Series X and Series X1 non-voting convertible preferred stock, basic and diluted			114,508				118,268
Net loss used in the calculation of basic and diluted loss per share		$	(36,184	)		$	(116,537	)
Net loss available to common stock		$	(31,992	)		$	(91,987	)
Net loss per share, common stock, basic and diluted		$	(0.66	)		$	(3.74	)
Net loss available to Series X and Series X1 non-voting convertible preferred stock		$	(4,192	)		$	(24,550	)
Basic and diluted earnings per share of Series X and Series X1 non-voting convertible preferred stock		$	(36.61	)		$	(207.58	)

Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive

The following table provides a summary as of December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.

		Year Ended December 31,
		2024				2023
Stock options outstanding and other equity awards			6,007,789				14,909,155
Common and preferred warrants outstanding			18,567,751				18,577,332
Total			24,575,540				33,486,487

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration